In vivo ectopic implantation model to assess human mesenchymal progenitor cell potential

Stem Cell Reviews and Reports

Volumn 9, Issue 6, 2013, Pages 833-846

  Abarrategi, Ander ^a   Perez Tavarez, Raquel ^a   Rodriguez Milla, Miguel Angel ^a   Cubillo, Isabel ^a   Mulero, Francisca ^c   Alfranca, Arantzazu ^a   Lopez Lacomba, Jose Luis ^b   García Castro, Javier ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Animal model; Ceramics .BMP 2; Mesenchymal cells

Indexed keywords

ANIMALIA; MUS;

BONE MORPHOGENETIC PROTEIN 2; FIBRIN; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CERAMICS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HUMAN; IMPLANT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; NONOBESE DIABETIC MOUSE; PHENOTYPE; SCID MOUSE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CERAMICS; FIBRIN; HUMANS; IMPLANTS, EXPERIMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; TISSUE SCAFFOLDS;

EID: 84898997306     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-013-9464-1     Document Type: Article

References (83)

1. Bianco, P., Cao, X., Frenette, P. S., et al. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nature Medicine, 19, 35-42.
2. Wang, S., Qu, X., & Zhao, R. C. (2012). Clinical applications of mesenchymal stem cells. Journal of Hematology & Oncology, 5, 19.
3. Otto, W. R., & Wright, N. A. (2011). Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair, 4, 20.
4. Si, Y. L., Zhao, Y. L., Hao, H. J., Fu, X. B., & Han, W. D. (2011). MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing research reviews, 10, 93-103.
5. Backly, R., & Cancedda, R. (2010). Bone marrow stem cells in clinical application: harnessing paracrine roles and niche mechanisms. Bioreactor Systems for Tissue Engineering II, 265-292.
6. Barry, F. P., & Murphy, J. M. (2004). Mesenchymal stem cells: clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology, 36, 568-584.
7. Le Blanc, K., & Ringdén, O. (2005). Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 321-334.
8. Russell, K. C., Phinney, D. G., Lacey, M. R., Barrilleaux, B. L., Meyertholen, K. E., & O'Connor, K. C. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells, 28, 788-798.
9. Stenderup, K., Justesen, J., Clausen, C., &Kassem, M. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33, 919.
10. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
11. Deskins, D. L., Bastakoty, D., Saraswati, S., Shinar, A., Holt, G. E., & Young, P. P. (2013). Human mesenchymal stromal cells: identifying assays to predict potency for therapeutic selection. Stem Cells Translational Medicine, 2, 151-158.
12. Janicki, P., Boeuf, S., Steck, E., Egermann, M., Kasten, P., & Richter, W. (2011). Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. European Cells & Materials, 21, 488-507.
13. Bieback, K., Schallmoser, K., Klüter, H., & Strunk, D. (2008). Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfusion Medicine and Hemotherapy, 35, 286.
14. Bieback, K., Kinzebach, S., Karagianni, M. (2011). Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem cells international. doi: 10. 4061/2010/193519.
15. Scott, M. A., Levi, B., Askarinam, A., et al. (2011). Brief review of models of ectopic bone formation. Stem Cells and Development, 21, 655-667.
16. Bose, S., Roy, M., & Bandyopadhyay, A. (2012). Recent advances in bone tissue engineering scaffolds. Trends in Biotechnology, 30, 546-554.
17. Tuan, R. S., Boland, G., & Tuli, R. (2003). Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Research and Therapy, 5, 32-45.
18. Mauney, J. R., Volloch, V., & Kaplan, D. L. (2005). Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Engineering, 11, 787-802.
19. Scotti, C., Piccinini, E., Takizawa, H., et al. (2013). Engineering of a functional bone organ through endochondral ossification. Proceedings of the National Academy of Sciences, 110, 3997-4002.
20. Bianco, P., Kuznetsov, S. A., Riminucci, M., Fisher, L. W., Spiegel, A. M., & Robey, P. G. (1998). Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. The Journal of Clinical Investigation, 101, 1737.
21. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131, 324-336.
22. Mankani, M. H., Kuznetsov, S. A., Marshall, G. W., & Robey, P. G. (2008). Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Engineering. Part A, 14, 1949-1958.
23. Kuznetsov, S. A., Mankani, M. H., & Robey, P. G. (2011). In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. Journal of Tissue Engineering and Regenerative Medicine, 7, 226-235.
24. Mankani, M. H., Kuznetsov, S. A., Avila, N. A., Kingman, A., & Robey, P. G. (2004). Bone formation in transplants of human bone marrow stromal cells and hydroxyapatite-tricalcium phosphate: prediction with quantitative CT in mice. Radiology, 230, 369-376.
25. Krebsbach, P. H., Kuznetsov, S. A., Satomura, K., Emmons, R. V. B., Rowe, D. W., & Robey, P. G. (1997). Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation, 63, 1059-1069.
26. Arinzeh, T. L., Tran, T., Mcalary, J., & Daculsi, G. (2005). A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials, 26, 3631-3638.
27. Mankani, M. H., Kuznetsov, S. A., Fowler, B., Kingman, A., & Gehron Robey, P. (2000). In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnology and Bioengineering, 72, 96-107.
28. Isern, J., Martín-Antonio, B., Ghazanfari, R., et al. (2013). Selfrenewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell reports., 3, 1714-1724.
29. Méndez-Ferrer, S., Michurina, T. V., Ferraro, F., et al. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 466, 829-834.
30. Isern, J., &Méndez-Ferrer, S. (2011). Stem cell interactions in a bone marrow niche. Current osteoporosis reports, 9, 210-218.
31. Barradas, A., Yuan, H., Blitterswijk, C. A., & Habibovic, P. (2011). Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. European cells & materials, 21, 407-429.
32. Zhang, H., & Bradley, A. (1996). Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development, 122, 2977-2986.
33. Kugimiya, F., Ohba, S., Nakamura, K., Kawaguchi, H., & Chung, U. (2006). Physiological role of bone morphogenetic proteins in osteogenesis. Journal of Bone and Mineral Metabolism, 242, 95-99.
34. Kloen, P., Lauzier, D., & Hamdy, R. C. (2012). Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions. Bone, 51, 59-68.
35. Onishi, T., Ishidou, Y., Nagamine, T., et al. (1998). Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone, 22, 605-612.
36. Ngo, T. Q., Scherer, M. A., Zhou, F. H., Foster, B. K., & Xian, C. J. (2006). Expression of bonemorphogenic proteins and receptors at the injured growth plate cartilage in young rats. Journal of Histochemistry & Cytochemistry, 54, 945-954.
37. Kwon, S. H., Lee, T. J., Park, J., et al. (2012). Modulation of BMP-2-induced chondrogenic versus osteogenic differentiation of human mesenchymal stem cells by cell-specific extracellular matrices. Tissue Engineering. Part A, 19, 49-58.
38. Freyria, A., Courtes, S., & Mallein-Gerin, F. (2008). Differentiation of adult human mesenchymal stem cells: chondrogenic effect of BMP-2. Pathologie Biologie, 56, 326-333.
39. Majumdar, M. K., Wang, E., & Morris, E. A. (2001). BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Journal of Cellular Physiology, 189, 275-284.
40. Scott, M. A., Nguyen, V. T., Levi, B., &James, A. W. (2011). Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells and Development, 20, 1793-1804.
41. Park, J. C., Kim, J., Kim, B. K., et al. (2012). Dose-and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells. J. Periodont. Res., 47, 645-654.
42. Kang, Q., Song, W. X., Luo, Q., et al. (2008). A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem cells and development, 18, 545-558.
43. Huang, H. Y., Hu, L. L., Song, T. J., et al. (2011). Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4. Molecular & Cellular Proteomics, 10.
44. Cannon, B., & Nedergaard, J. (2008). Developmental biology: neither fat nor flesh. Nature, 454, 947-948.
45. Abarrategi, A., Moreno-Vicente, C., Martínez-Vázquez, F. J., et al. (2012). Biological properties of solid free form designed ceramic scaffolds with BMP-2: in vitro and in vivo evaluation. PloS one, 7, e34117.
46. Funes, J. M., Quintero, M., Henderson, S., et al. (2007). Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proceedings of the National Academy of Sciences, 104, 6223-6228.
47. Abarrategi, A., Moreno-Vicente, C., Ramos, V., Aranaz, I., Sanz Casado, J., & López-Lacomba, J. (2008). Improvement of porous b-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application. Tissue Engineering Part, A14, 1305-1319.
48. Abarrategi, A., Civantos, A., Ramos, V., Sanz Casado, J. V., & López-Lacomba, J. L. (2007). Chitosan film as rhBMP2 carrier: delivery properties for bone tissue application. Biomacromolecules, 9, 711-718.
49. Dennis, J. E., & Charbord, P. (2002). Origin and differentiation of human and murine stroma. Stem Cells, 20, 205-214.
50. Oswald, J., Boxberger, S., Jørgensen, B., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22, 377-384.
51. Portalska, K. J., Leferink, A., Groen, N., et al. (2012). Endothelial differentiation of mesenchymal stromal cells. PloS one, 7, e46842.
52. Limbert, C., Päth, G., Ebert, R., et al. (2011). PDX1-and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. Cytotherapy, 13, 802-813.
53. Rai, B., Lin, J. L., Lim, Z. X. H., Guldberg, R. E., Hutmacher, D. W., & Cool, S. M. (2010). Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials, 31, 7960-7970.
54. Chai, Y. C., Roberts, S. J., Desmet, E., et al. (2012). Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials, 33, 3127-3142.
55. González-Cruz, R. D., Fonseca, V. C., & Darling, E. M. (2012). Cellular mechanical properties reflect the differentiation potential of adipose-derived mesenchymal stem cells. Proceedings of the National Academy of Sciences, 109, E1523-E1529.
56. Mathieu, P. S., & Loboa, E. G. (2012). Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Engineering. Part B, Reviews, 18, 436-444.
57. Peng, R., Yao, X., & Ding, J. (2011). Effect of cell anisotropy on differentiation of stem cells on micropatterned surfaces through the controlled single cell adhesion. Biomaterials, 32, 8048-8057.
58. Burns, J. S., Rasmussen, P. L., Larsen, K. H., Schrøder, H. D., & Kassem, M. (2010). Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Engineering. Part A, 16, 2331-2342.
59. Gärtner, A., Pereira, T., Armada-da-Silva, P., et al. (2012). Use of poly (DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis. Differentiation, 84, 355-365.
60. Abarrategi, A., Marinas-Pardo, L., Mirones, I., Rincon, E., & Garcia-Castro, J. (2011). Mesenchymal niches of bone marrow in cancer. Clinical and Translational Oncology, 13, 611-616.
61. Bianco, P. (2011). Bone and the hematopoietic niche: a tale of two stem cells. Blood, 117, 5281-5288.
62. Barrère, F., Van Blitterswijk, C. A., & De Groot, K. (2006). Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. International Journal of Nanomedicine, 1, 317.
63. Papadimitropoulos, A., Mastrogiacomo, M., Peyrin, F., et al. (2007). Kinetics of in vivo bone deposition by bone marrow stromal cells within a resorbable porous calcium phosphate scaffold: an X-ray computed microtomography study. Biotechnology and Bioengineering, 98, 271-281.
64. Jaquiéry, C., Schaeren, S., Farhadi, J., et al. (2005). In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Annals of Surgery, 242, 859.
65. Komlev, V., Mastrogiacomo, M., Pereira, R., Peyrin, F., Rustichelli, F., & Cancedda, R. (2010). Biodegradation of porous calcium phosphate scaffolds in an ectopic bone formationmodel studied byX-ray computed microtomograph. European Cells & Materials, 19, 136-146.
66. Komlev, V., Peyrin, F., Mastrogiacomo, M., et al. (2006). Kinetics of in vivo bone deposition by bone marrow stromal cells into porous calcium phosphate scaffolds: an X-ray computed microtomography study. Tissue Engineering, 12, 3449-3458.
67. Janicki, P., Kasten, P., Kleinschmidt, K., Luginbuehl, R., & Richter, W. (2010). Chondrogenic pre-induction of humanmesenchymal stem cells on β-TCP: enhanced bone quality by endochondral heterotopic bone formation. Acta Biomaterialia, 6, 3292-3301.
68. Ye, X., Yin, X., Yang, D., Tan, J., & Liu, G. (2012). Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bonemarrowmesenchymal stemcells in beta-tricalciumphosphate scaffolds. Tissue Engineering. Part C, Methods, 18, 545-556.
69. Kasten, P., Vogel, J., Luginbühl, R., et al. (2005). Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials, 26, 5879-5889.
70. Nan, K., Sun, S., Li, Y., Chen, H., Wu, T., & Lu, F. (2010). Ectopic osteogenic ability of calcium phosphate scaffolds cultured with osteoblasts. Journal of Biomedical Materials Research Part A, 93, 464-468.
71. Schubert, T., Xhema, D., Vériter, S., et al. (2011). The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells. Biomaterials, 32, 8880-8891.
72. Roberts, S. J., Geris, L., Kerckhofs, G., Desmet, E., Schrooten, J., & Luyten, F. P. (2011). The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials, 32, 4393-4405.
73. Date, T., Doiguchi, Y., Nobuta, M., & Shindo, H. (2004). Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. Journal of Orthopaedic Science, 9, 503-508.
74. Spicer, P. P., & Mikos, A. G. (2010). Fibrin glue as a drug delivery system. Journal of Controlled Release, 148, 49-55.
75. Ahmed, T. A. E., Dare, E. V., & Hincke, M. (2008). Fibrin: a versatile scaffold for tissue engineering applications. Tissue Engineering. Part B, Reviews, 14, 199-215.
76. Le Guéhennec, L., Layrolle, P., & Daculsi, G. (2004). A review of bioceramics and fibrin sealant. European Cells & Materials, 8, 1-11.
77. Janmey, P. A., Winer, J. P., & Weisel, J. W. (2009). Fibrin gels and their clinical and bioengineering applications. Journal of the Royal Society, Interface, 6, 1-10.
78. LeNihouannen, D., Goyenvalle, E., Aguado, E., et al. (2007). Hybrid composites of calcium phosphate granules, fibrin glue, and bone marrow for skeletal repair. Journal of Biomedical Materials Research Part A, 81, 399-408.
79. Anitua, E., Prado, R., Orive, G. (2013). Endogenousmorphogens and fibrin bioscaffolds for stem cell therapeutics. Trends Biotechnol, 31, 364-374.
80. Anitua, E., Tejero, R., Alkhraisat, M. H., &Orive, G. (2013). Plateletrich plasma to improve the bio-functionality of biomaterials. BioDrugs, 1-15.
81. Laflamme, C., Curt, S., & Rouabhia, M. (2010). Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Archives of Oral Biology, 55, 689-701.
82. Scotti, C., Tonnarelli, B., Papadimitropoulos, A., et al. (2010). Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proceedings of the National Academy of Sciences, 1076, 7251-7256.
83. Al-Nbaheen, M., Ali, D., Bouslimi, A., et al. (2013). Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Reviews and Reports, 9, 32-43.